Other3

Biohaven Ltd.

Total Value

$NaN

Filing Date

Aug 14, 2026

1 transactions

Trade Summary

On Aug 6, 2026, Yetimoglu John, Director, reported $NaN of Biohaven Ltd. (BHVN) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Insider Information

Name: Yetimoglu John
Role: Director
Location: NEW HAVEN, CT

Filing Details

Filing Date: Aug 14, 2026
Transaction Date: Aug 6, 2026
Accession Number: 0002150506-26-000002
Form Type: 3

Want live alerts when Yetimoglu John trades again?

Download Insider Trades to track BHVN, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)Represents 6,250,000 Common Shares held by Infinitum Cayman Master, Ltd. Mr. Yetimoglu, in his capacity as Chief Investment Officer of Infinitum Partners, GP LLC, may be deemed to have voting and investment control of the shares held by Infinitum Cayman Master, Ltd. Mr. Yetimoglu disclaims beneficial ownership of any shares owned by Infinitum Cayman Master, Ltd., except to the extent of his pecuniary interests therein.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Yetimoglu John

(Last)

(First)

(Middle)

215 CHURCH STREET

(Street)

NEW HAVEN

06510

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/06/2026

3. Issuer Name and Ticker or Trading Symbol
Biohaven Ltd. [ BHVN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	6,250,000	I	See Footnote⁽¹⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

1. Represents 6,250,000 Common Shares held by Infinitum Cayman Master, Ltd. Mr. Yetimoglu, in his capacity as Chief Investment Officer of Infinitum Partners, GP LLC, may be deemed to have voting and investment control of the shares held by Infinitum Cayman Master, Ltd. Mr. Yetimoglu disclaims beneficial ownership of any shares owned by Infinitum Cayman Master, Ltd., except to the extent of his pecuniary interests therein.

Remarks:

Exhibit List: Exhibit 24: Power of attorney

	/s/ George Clark, Attorney-in-Fact	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 3 as rendered by the SEC from accession 0002150506-26-000002.

Biohaven Ltd.

Trade Summary

Company Information

Insider Information

Filing Details

Want live alerts when Yetimoglu John trades again?

Footnotes

SEC Form 3

SEC Filing

SEC Form 3